Spero Therapeutics, Inc.
Nasdaq: SPRO
- Raised $9 million (2022)
- 22 clinical trials
- Research grants: $2 million
- Founded 2013
Life science companies
Explore 33,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Champions Oncology
Nasdaq: CSBROn BioBridgeX
- Raised $14 million (2015)
- 1 clinical trial
- Research grants: $2 million
Opus Genetics, Inc.
Nasdaq: IRD
- Raised $26 million (2024)
- 3 clinical trials, 3 active
- Research grants: $4.5 million
- Founded 2021
PTC Therapeutics, Inc.
Nasdaq: PTCT
- Raised $36 million (2023)
- 66 clinical trials, 5 active
- Research grants: $6.2 million
Heartflow, Inc.
Nasdaq: HTFL
- Raised $65 million (2019)
- 16 clinical trials, 5 active
- FDA-cleared or approved devices
- Research grants: $338,268
Alto Neuroscience, Inc.
NYSE: ANRO
- Raised $50 million (2025)
- 12 clinical trials, 4 active
- Research grants: $6.4 million
- Founded 2019
NeuroSigma, Inc.
- Raised $12 million (2016)
- 1 clinical trial
- FDA-cleared or approved devices
- Research grants: $12 million
Solventum Corp
NYSE: SOLV
- 64 clinical trials, 2 active
- FDA-cleared or approved devices
- 2 FDA-registered drug sites
Becton Dickinson & Co
NYSE: BDX
- 66 clinical trials, 6 active
- FDA-cleared or approved devices
- 2 FDA-registered drug sites
Humacyte, Inc.
Nasdaq: HUMA
- Raised $150 million (2018)
- 15 clinical trials, 4 active
- 1 FDA-registered drug site
- Research grants: $7.5 million
Cepheid
- Raised $5.2 million (2013)
- 10 clinical trials, 1 active
- FDA-cleared or approved devices
- Research grants: $8.3 million
Amgen Inc
Nasdaq: AMGN
- Private funding (2015)
- 1118 clinical trials, 106 active
- 4 FDA-registered drug sites
- Research grants: $600,000
Delcath Systems, Inc.
Nasdaq: DCTH
- Raised $7 million (2024)
- 11 clinical trials, 3 active
- 2 FDA-registered device sites
- 1 FDA-registered drug site
Design Therapeutics, Inc.
Nasdaq: DSGN
- Raised $125 million (2021)
- 5 clinical trials, 3 active
- Research grants: $1.1 million
- Founded 2017
Biotricity Inc.
OTC: BTCY
- Raised $1 million (2024)
- FDA-cleared or approved devices
- Research grants: $480,106
- Founded 2012
Twist Bioscience
Nasdaq: TWSTOn BioBridgeX
- Raised $50 million (2018)
- 1 FDA-registered device site
- Founded 2013
Spark Biomedical Inc.
- Raised $16 million (2023)
- 16 clinical trials, 6 active
- FDA-cleared or approved devices
- Research grants: $12 million
Aprea Therapeutics, Inc.
Nasdaq: APRE
- Raised $3.1 million (2025)
- 12 clinical trials, 1 active
- Research grants: $4 million
Arvinas, Inc.
Nasdaq: ARVN
- Raised $32 million (2019)
- 5 clinical trials, 3 active
- Research grants: $2.1 million
- Founded 2013
Soleno Therapeutics Inc
- Raised $60 million (2023)
- 7 clinical trials, 2 active
- Research grants: $4.4 million
Showing 60 of 33,266 companies
Load morePublished company profiles only; counts update daily. Data licences